Industry Experts - Market Research

Global Biomarkers Market to Grow Robustly and Reach US$174 Billion by 2030, Owing to the Demand for Personalized Medicine, Drug Development, and Diagnostics

Monday Feb 03, 2025

The new report from Industry Experts, Inc., on "Biomarkers Market", is unveiled. The global Biomarkers market is estimated at US$81.7 billion in 2024 and is projected to grow to US$173.8 billion by 2030, exhibiting a CAGR of 13.4% over the period from 2024 to 2030.

The market for biomarkers is propelled by the rising incidence of chronic conditions such as cancer, diabetes, neurological, and cardiovascular diseases, as well as a growing need for early detection and precision medicine. Innovations in genomics, proteomics, and high-throughput screening have improved the discovery of biomarkers with greater specificity and sensitivity. Biomarkers are essential in drug development because they enhance efficiency, reduce costs, and streamline clinical trials. Biomarkers facilitate targeted therapies, which lead to better treatment outcomes and decreased healthcare expenses. Their incorporation into diagnostics, disease monitoring, and drug development highlights their vital importance in modern healthcare.

The efficacy biomarkers segment is anticipated to witness the fastest growth rate with a CAGR of 14.9% from 2024 to 2030, owing to its crucial role in assessing drug efficacy and forecasting patient responses. Efficacy biomarkers facilitate personalized medicine, improve therapeutic results, and are essential for the success of clinical trials, driving their integration into precision medicine and drug discovery efforts.

The market for biomarkers analyzes in this report on a global basis covering all major regions across North America (The United States, Canada, and Mexico), Europe (Germany, France, United Kingdom, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), and Rest of the World.

The study analyzes the global market for biomarkers based on Type – Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers; Technology – Omics Technologies: Genomics, Proteomics, Metabolomics, Transcriptomics, Other Omics Technologies (Including Epigenomics, Lipidomics, Glycomics, and others), Bioimaging, Bioinformatics; Disease Indication – Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Other Disease Indications (Including Renal Diseases, Metabolic Diseases, Hematological Diseases, and others); and Application – Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Other Applications (Including Disease Monitoring & Prognosis, Research, Forensic Applications, and others).

About Industry Experts, Inc.
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers, and startups, among others, to obtain valuable, crisp, and unbiased current and future market data. For more information, contact us at +1-320-497-3787 or visit https://industry-experts.com/